ANNA ROOKS: Open Payments
NPI 1497583975 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 38 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $523 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Biosense Webster, Inc. | 2 | $82 |
| Stemline Therapeutics Inc. | 2 | $48 |
| Celgene Corporation | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Exelixis Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $33 |
Products named: CARTO 3, TEVIMBRA, CALQUENCE, Orserdu, REBLOZYL, BRUKINSA, KEYTRUDA, CABOMETYX.
Industry payments across AL — which companies pay providers there.
